XCR1 and cancer: CD6, CCL19, ATM, CD40LG and XCR1 were identified as the most significantly differentially expressed by nSolver (NanoString Technologies, Inc.), and MAGEA1, ATM and CCL19 were identified by NanoStringDiff (NanoString Technologies, Inc.)as the most significant differentially expressed genes in MET-altered cancers.